WNK1 Activates SGK1 to Regulate the Epithelial Sodium Channel
WNK (with no lysine [K]) kinases are serine-threonine protein kinases with an atypical placement of the catalytic lysine. Intronic deletions increase the expression of WNK1 in humans and cause pseudohypoaldosteronism type II, a form of hypertension. WNKs have been linked to ion carriers, but the und...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 29; pp. 10315 - 10320 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
19.07.2005
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | WNK (with no lysine [K]) kinases are serine-threonine protein kinases with an atypical placement of the catalytic lysine. Intronic deletions increase the expression of WNK1 in humans and cause pseudohypoaldosteronism type II, a form of hypertension. WNKs have been linked to ion carriers, but the underlying regulatory mechanisms are unknown. Here, we report a mechanism for the control of ion permeability by WNK1. We show that WNK1 activates the serum- and glucocorticoid-inducible protein kinase SGK1, leading to activation of the epithelial sodium channel. Increased channel activity induced by WNK1 depends on SGK1 and the E3 ubiquitin ligase Nedd4-2. This finding provides compelling evidence that this molecular mechanism contributes to the pathogenesis of hypertension in pseudohypoaldosteronism type II caused by WNK1 and, possibly, in other forms of hypertension. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Communicated by David L. Garbers, University of Texas Southwestern Medical Center, Dallas, TX, May 27, 2005 Author contributions: B.-e.X., C.-L.H., and M.H.C. designed research; B.-e.X., S.S., P.-Y.C., A.L., X.-J.L., B.-H.L., J.M.E., and B.O. performed research; B.-e.X., S.S., P.-Y.C., A.L., X.-J.L., B.-H.L., J.M.E., B.O., C.-L.H., and M.H.C. analyzed data; and B.-e.X., C.-L.H., and M.H.C. wrote the paper. Abbreviations: CHO, Chinese hamster ovary; ENaC, epithelial sodium channel; KD, kinase-dead; NCC, sodium chloride cotransporter; PHA II, pseudohypoaldosteronism type II. To whom correspondence may be addressed. E-mail: melanie.cobb@utsouthwestern.edu or chou-long.huang@utsouthwestern.edu. Present address: Pfizer Research and Technology, 620 Memorial Drive, Cambridge, MA 02139. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0504422102 |